{"title":"Bacterial superinfection in pregnant women with severe COVID-19: Prevalence, resistance patterns and outcomes","authors":"Mojtaba Akbari , Mohammad Shirzadi , Fatemeh Yazdani , Samaneh Pourajam , Majid Hosseinzadeh , Armita akbari , Mansour Siavash , Hamid Solgi","doi":"10.1016/j.jiph.2026.103184","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pregnant women with severe COVID-19 are at high risk for intensive care unit (ICU) admission and adverse maternal outcomes. Evidence on the burden and impact of bacterial infections in this group is limited.</div></div><div><h3>Methods</h3><div>We conducted a single-center retrospective cohort study of pregnant women with confirmed COVID-19 admitted for ≥ 48 h to the ICU of a referral maternity hospital in Isfahan, Iran, between June and December 2021. Clinical, demographic, microbiological, and outcome data were retrieved from electronic medical records. Bacterial isolates were identified and tested for antimicrobial susceptibility according to CLSI guidelines. Logistic regression was performed to determine factors independently associated with in-hospital mortality.</div></div><div><h3>Results</h3><div>Of 527 pregnant women hospitalized with COVID-19, 71 required ICU admission and were included in the analysis. Bacterial infections were detected in 8 patients (11.3 %), most frequently caused by multidrug-resistant (MDR) <em>Klebsiella pneumoniae</em>. Compared with non-infected patients, women with bacterial superinfections had significantly longer hospital stays (22.4 vs. 10.2 days, p < 0.001) and ICU stays (16.8 vs. 5.2 days, p < 0.001), higher rates of invasive mechanical ventilation (50.0 % vs. 9.5 %, p = 0.002), and increased mortality (37.5 % vs. 9.5 %, p = 0.025). Univariate analyses identified bacterial superinfection, MDR pathogens, carbapenem/vancomycin use, lower admission SpO₂, and carbapenem-resistant <em>K. pneumoniae</em> as predictors of death. In multivariate analysis, only bacterial superinfection (aOR = 13.35, 95 % CI: 1.05–170.06) and lower oxygen saturation at admission (aOR = 1.21 per 1 % decrease, 95 % CI: 1.06–1.38) remained independent predictors of mortality.</div></div><div><h3>Conclusion</h3><div>Bacterial superinfections, especially with multidrug-resistant pathogens, are relatively common in ICU-hospitalized pregnant women with COVID-19 and strongly linked to worse outcomes, including higher mortality. Early detection, infection control, and rational antibiotic use are essential to improve survival.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103184"},"PeriodicalIF":4.8000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034126000560","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Pregnant women with severe COVID-19 are at high risk for intensive care unit (ICU) admission and adverse maternal outcomes. Evidence on the burden and impact of bacterial infections in this group is limited.
Methods
We conducted a single-center retrospective cohort study of pregnant women with confirmed COVID-19 admitted for ≥ 48 h to the ICU of a referral maternity hospital in Isfahan, Iran, between June and December 2021. Clinical, demographic, microbiological, and outcome data were retrieved from electronic medical records. Bacterial isolates were identified and tested for antimicrobial susceptibility according to CLSI guidelines. Logistic regression was performed to determine factors independently associated with in-hospital mortality.
Results
Of 527 pregnant women hospitalized with COVID-19, 71 required ICU admission and were included in the analysis. Bacterial infections were detected in 8 patients (11.3 %), most frequently caused by multidrug-resistant (MDR) Klebsiella pneumoniae. Compared with non-infected patients, women with bacterial superinfections had significantly longer hospital stays (22.4 vs. 10.2 days, p < 0.001) and ICU stays (16.8 vs. 5.2 days, p < 0.001), higher rates of invasive mechanical ventilation (50.0 % vs. 9.5 %, p = 0.002), and increased mortality (37.5 % vs. 9.5 %, p = 0.025). Univariate analyses identified bacterial superinfection, MDR pathogens, carbapenem/vancomycin use, lower admission SpO₂, and carbapenem-resistant K. pneumoniae as predictors of death. In multivariate analysis, only bacterial superinfection (aOR = 13.35, 95 % CI: 1.05–170.06) and lower oxygen saturation at admission (aOR = 1.21 per 1 % decrease, 95 % CI: 1.06–1.38) remained independent predictors of mortality.
Conclusion
Bacterial superinfections, especially with multidrug-resistant pathogens, are relatively common in ICU-hospitalized pregnant women with COVID-19 and strongly linked to worse outcomes, including higher mortality. Early detection, infection control, and rational antibiotic use are essential to improve survival.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.